Clinical Trial Update: Brentuximab Vedotin or Crizotinib and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II-IV Anaplastic Large Cell Lymphoma [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating Brentuximab Vedotin or Crizotinib in combination with chemotherapy for newly diagnosed Anaplastic Large Cell Lymphoma (including ALK-…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anaplastic Large Cell Lymphoma

Drugs mentioned

• Brentuximab vedotin (Brentuximab vedotin)
• Crizotinib (crizotinib)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Anaplastic Large Cell Lymphoma, ALK-Positive, Ann Arbor Stage II Noncutaneous Childhood Anaplastic Large Cell Lymphoma | Phase 2 | Status: COMPLETED | Results posted: 2022-07-06